Detalhe da pesquisa
1.
CNX-012-570, a direct AMPK activator provides strong glycemic and lipid control along with significant reduction in body weight; studies from both diet-induced obese mice and db/db mice models.
Cardiovasc Diabetol
; 13: 27, 2014 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-24460834
2.
A novel 11ß-hydroxysteroid dehydrogenase type1 inhibitor CNX-010-49 improves hyperglycemia, lipid profile and reduces body weight in diet induced obese C57B6/J mice with a potential to provide cardio protective benefits.
BMC Pharmacol Toxicol
; 15: 43, 2014 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-25098735